Coronavirus updates | August 30, 2021 | Recruitment of volunteers for trial of Covid vaccine 'Covovax' on children begins

Union Minister Mansukh Mandaviya on August 29 released the first commercial batch of COVID-19 vaccines manufactured

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine ‘Covovax’ among children aged 2 to 17 years began on August 29 at the Hamdard Institute of Medical Sciences and Research.

Union Minister of Health and Family Welfare Mansukh Mandaviya on August 29 released the first commercial batch of COVID-19 vaccine manufactured in Ankleshwar, Gujarat.

You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.

Here are the latest updates:

Goa government extends COVID-19 curfew till September 6

The Goa government has once again extended the COVID-19 induced statewide curfew till September 6.

A notification to this effect was issued on Sunday.

The 24-hour curfew was first imposed on May 9 this year and since then it has been extended regularly.

The Goa government has opened the majority of activities in the tourist state but the areas like casinos are yet to be reopened.

New Zealand reports death of woman after Pfizer COVID vaccine

On August 30 New Zealand reported that a woman had died following her Comirnaty Pfizer COVID-19 vaccination.

An independent COVID-19 vaccine safety monitoring board considered that the woman’s death was due to myocarditis, which is known to be a rare side effect of the Pfizer COVID-19 vaccine, the Health Ministry said in a statement.

The board noted there were other medical issues occurring at the same time which may have influenced the outcome following vaccination, the statement said. – Reuters

Read more

Recruitment of volunteers for trial of Covid vaccine ‘Covovax’ on children begins

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine ‘Covovax’ among children aged 2 to 17 years began on August 29 at the Hamdard Institute of Medical Sciences and Research.

The trial would be held across 10 sites and would cover 920 children, 460 each in the age groups of 12-17 and 2-11 according to official sources.

Indigenously developed Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country. – PTI

Source: Read Full Article